Lyme Brain & Fibro Fog
Live Webinar with Dr. Bill Rawls

Suffering from chronic Lyme disease is bad enough. Add to that a coinfection such as Epstein-Barr Virus, Mycoplasma, or Bartonella, and your illness can become even more severe, plus recovery can take significantly longer. But while overcoming these coinfections is a challenge, it is possible — and you don’t have to do it all alone.

Join a live webinar with Dr. Bill Rawls, author of the best-selling book Unlocking Lyme, who knows firsthand what it’s like to struggle with chronic Lyme disease. You’ll discover what really matters when it comes to diagnosing common Lyme disease coinfections, plus the best natural and conventional remedies for easing symptoms and restoring your health.

Join Dr. Bill Rawls for this new LIVE WEBINAR on Wednesday, December 11th, at 8pm EST as he explains what’s to blame for the brain and neurological symptoms that can come with chronic Lyme and fibromyalgia, and shares natural remedies for effective and lasting relief.

Since his recovery more than a decade ago, Dr. Rawls has helped thousands of patients find their path to healing from Lyme disease and coinfections. Now, he’d like to help you. Come with your questions, and he’ll answer as many of them as possible. PLUS: Don’t miss an exclusive gift for those who attend the live webinar.

“Dr Rawls’ perspective as both physician and patient (now recovered).He shares the BEST info with CARE and COMPASSION. I always learn something that is important to me and I do study and research daily. We are striving to heal our dear son.” – Lee S.


“Knowing that there is another respected physician who understands Lyme…. VERY HOPEFUL!” – Nancy A.

In this webinar, Dr. Rawls will also discuss:

  • Why neurological symptoms like confusion, short-term memory loss, anxiety, and depression are so common in chronic illness patients
  • How microbes, inflammation, and immune malfunction disrupt cognitive function
  • The best herbs and natural remedies for restoring and protecting brain health
  • Diet tips, essential oils, and other lifestyle factors that help ease symptoms
  • Numerous insights during the live Q&A with Dr. Rawls


Can Bee Stings Treat Lyme Disease?

Treatments for chronic Lyme disease are controversial and expensive. As a last resort, some patients are pursuing this unproven and painful alternative.

When Tricia Gschwind pulled up to a Whataburger along I-35 in Round Rock one morning last May, she wasn’t craving a breakfast platter. She was there to make an exchange. “I never bought drugs at a Whataburger,” she said, easing into a parking space. “I assume this is what that’s like.”

Gschwind (pronounced GISH-wind) stepped out of her car, straightening her royal blue cat-eye sunglasses as strands of her hair flitted in the breeze. She recognized a Toyota SUV that arrived some thirty seconds later. A graying beekeeper in a polo shirt approached. His name was Jim Colbert, and after a quick hello, they got right down to business. Into Gschwind’s hands he delicately placed two four-inch-long wooden palettes—imagine tiny, mesh-covered mancala boards—each holding about fifty live honeybees, buzzing softly.“I guess this is drone season,” Gschwind said, alluding to the previous batch of bees she’d purchased from him, which had included some stinger-less males. Gschwind needed bees that could sting. “Is that why it’s not unusual for me to find so many drones in the mix?” (See link for full article)


For more:

Another patient, Deb, has regained her health due to Bee Venomon Therapy (BVT):

 “I’m getting my life back. I have control of my healing. Best of all my sense of humor is restored. This feels great. If I can get better in mere months of treatment, anyone can!”  


“This is a highly effective form of treatment which most any patient can afford. I was spending $32/month for my mail order bees and treating at home.”

For videos by Deb go to:!videos/cuzq

For Deb’s site and to read about her journey, go to:!home/c121p

Apitherapy to treat Lyme & Co-infections  Eugene OR  (For the written protocol, vendor links, and more materials go to:

The administration wants to require hospitals to reveal the rates they privately negotiate with insurers for all sorts of procedures, amid the public outcry over surprise medical bills.

The hospital groups argue in their lawsuit that the rule will not accomplish the administration’s aim of helping consumers avoid surprise bills.
Credit…Hilary Swift for The New York Times

The hospitals, including the American Hospital Association, argued in a lawsuit filed in United States District Court in Washington that the new rule “is unlawful, several times over.”  (See link for full article)


For more:

03 DEC 2019

TOUCHED BY LYME: Latest in anti-IDSA/insurers lawsuit: Kaiser settles.  10-Points- Suing Architects of Lyme Policy As Task Force Meets to Review it

Multiple Sclerosis and psychosis: A case report

Jasreen Cheemaa,low asterisk,'Correspondence information about the author Jasreen Cheema
Aline-Claire Huyhb
Sébastien S. Pratc,d


  • Co-occurrence of MS and a psychiatric condition needs to be carefully explored.
  • Case description of Multiple Sclerosis with psychotic features remains limited.
  • Inappropriate advertisement of chronic disease may impede patient’s recovery.


Psychiatric symptoms resulting from Multiple Sclerosis (MS) itself or its treatment are well known. However, the relationship between psychotic episodes and Multiple Sclerosis remains debated. In this paper, we present the case of a woman who developed a chronic psychotic disorder a few months after the onset of MS. We describe the process which led us to make the diagnosis of Psychotic Disorder due to Medical Condition (Multiple Sclerosis). Because her criminal charges brought significant attention to her case, we also address the difficulty in treating a neurological condition with psychiatric features within the forensic context. Moreover, one of the main concerns of the patient was that Lyme Disease was the correct diagnosis as opposed to MS. We also report the difficulty of treating and initiating successful follow-up for a patient whose paranoia is enabled by the opinions of certain health advocacy groups.



What’s sad is the patient could be absolutely right.

Since 2-tiered testing is so abysmal she needs an experienced Lyme/MSIDS practitioner to determine if she has clinical symptoms. Most mainstream practitioners are not educated in this.

Expect to see more of this.

Malaria Hides In People Without Symptoms

It seems like the never-ending battle against Malaria just keeps getting tougher. In regions where Malaria is hyper-prevalent, anti-mosquito measures can only work so well due to the reservoir that has built up of infected humans who do not even know they carry the infection.

In high-transmission areas, asymptomatic malaria is more prevalent than symptomatic malaria. Twenty-four percent of the people in sub-Saharan Africa are estimated to harbor an asymptomatic infection, including 38 to 50 percent of the school-aged children in western Kenya. Out of the 219 million malaria cases in 2017 worldwide, over 90%  were in sub-Saharan Africa….(See link for full article)



I post this because Malaria is a protozoan similar to Babesia.  The question begging to be asked is, “Can people also have an asymptomatic Babesia infection that lies around for an opportune time to emerge?”

My educated guess is yes, it can.

Key quote:  “P. falciparum malaria is very diverse in the region,” she said. “It’s constantly mutating, which is why it’s so hard to treat….many study participants were infected with multiple, genetically-distinct malaria infections. Some carried up to fourteen strains of the parasite.

For more:

We show that

  • burgdorferi infection attenuates parasitemia in mice while
  • B. microti subverts the splenic immune response, such that a marked decrease in splenic B and T cells, reduction in antibody levels and diminished functional humoral immunity, as determined by spirochete opsonophagocytosis, are observed in co-infected mice compared to only B. burgdorferi infected mice


  • immunosuppression by B. microti in coinfected mice showed an association with enhanced Lyme disease manifestations.
Due to the high prevalence of infection and the issues of congenital transmission and transmission through blood transfusion, the issue of concurrent infection and what it does to animal and human health is of paramount importance.

Assessing the Landscape of Eastern Equine Encephalitis Prevention and Treatment


The first case in the 2019 season was confirmed in August in Massachusetts. As of November 12, there have been 36 cases of the illness reported across 8 states. This is a sharp contrast to the 6 cases confirmed in 2018. More worrisome, one-third of the cases confirmed in 2019 have been fatal.Now, experts from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health have published a commentary in The New England Journal of Medicine describing the EEE virus along with research and development that is needed to address the growing threat of the virus and other vector-borne conditions.

The virus is typically spread between Culiseta melanura mosquitoes and birds that live in wetlands; however, other mosquito species can transmit the virus to humans and mammals. In the event of human infection, it takes approximately 3 to 10 days for symptoms to present.

Initial signs and symptoms include fever, muscle aches, nausea, and headache. Infection may progress to neurological EEE are “nonspecific” but progress rapidly and can be permanent. However, the authors of the report noted that 96% of individuals infected with EEE virus do not develop symptoms. Furthermore, specific diagnostic testing may not reveal the infection as the virus is difficult to isolate from clinical samples.

“Although point-of-care diagnostics for EEE and many other mosquito-borne causes of encephalitis are not available, currently they would be of limited value in the absence of effective treatment,” the authors of the report write.

Currently, there are no available antiviral drugs or vaccines that are safe and effective against EEE. At this point in time, patients with EEE are treated with supportive care including intensive care and ventilator assistance. Social support and counseling are recommended for the patient and their family members due to the serious, and sometimes long-term, effects of the infection.

According to NIAID’s statement, many compounds and candidates are currently in development. The authors note that monoclonal antibodies have demonstrated efficacy when given prior to infection in an animal model.

While there are several EEE vaccine candidates in development, the authors caution that these candidates may struggle to reach advance development and licensure. Vaccines that are mosquito-saliva based which are in development to protect against multiple mosquito-borne diseases are in early stages.

Moreover, due to the rare nature of the outbreaks which occur sporadically in unpredictable locations for short periods of time it is difficult to identify an appropriate target population for vaccination.

“In the absence of effective EEE vaccines and treatments, state and local health departments can provide an early warning of imminent human infections by surveilling horses, birds and mosquitoes, but these efforts are threatened by insufficient funding,” the authors said in the press release.

Despite the challenges to developing vaccines and treatments for EEE, the authors of the report caution that simply ignoring the virus would be irresponsible. While EEE outbreaks have been infrequent, a number of emerging and re-emerging mosquito-borne diseases such as dengue, West Nile, Zika, and chikungunya have been documented in the Americas in recent years.

“The spike in cases in 2019 and the looming presence of other, potentially deadly arboviruses in the United States and globally demand a national defense strategy for arboviruses and other vector-borne diseases,” the authors conclude.

Another detail to highlight is that the CDC does not mention these blood-sucking insects as a possible transmitter of Lyme borreliosis, which, although being low in the percentage shown in the studies, could be a factor in the spread of this disease by the world.